Hutchin Hill Capital’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Hutchin Hill Capital's AGN Position: Q4 2017 in Review
Hutchin Hill Capital reduced its Allergan plc (AGN) stake by 96% in Q4 2017, selling an estimated $8.88M and leaving 2,000 shares worth $327K. The position accounts for 0.09% of the portfolio, ranked #252.
Hutchin Hill Capital first reported a position in AGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $67.9M in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Hutchin Hill Capital held 2,000 shares of Allergan plc worth $327K as of Q4 2017.
- Hutchin Hill Capital sold 49,500 Allergan plc shares in Q4 2017, an estimated $8.88M.
- Allergan plc made up 0.09% of Hutchin Hill Capital's portfolio in Q4 2017, its #252 holding.
- Hutchin Hill Capital first reported a position in Allergan plc in Q2 2013 and has held it in 15 quarters since.
- Hutchin Hill Capital's Allergan plc position peaked at $67.9M in Q1 2015.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.